Nicolin Vanessa, De Tommasi Nunziatina, Nori Stefania Lucia, Costantinides Fulvia, Berton Federico, Di Lenarda Roberto
Clinical Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy.
Pharmacy-DIFARMA Department, University of Salerno, Fisciano, Italy.
Front Endocrinol (Lausanne). 2019 Jul 23;10:494. doi: 10.3389/fendo.2019.00494. eCollection 2019.
During the past, a more comprehensive knowledge of mechanisms implicated in bone resorption processes has driven researchers to develop a compound library of many small molecules that specifically interfere with the genesis of osteoclast precursors cells. Natural compounds that suppress osteoclast commitment may have therapeutic value in treating pathologies associated with bone resorption like osteoporosis, rheumatoid arthritis, bone metastasis, and periodontal disease. The present review is focused on the current knowledge on the polyphenols derived from plants that could be efficacious in suppressing osteoclast differentiation and bone resorption.
在过去,对骨吸收过程中涉及的机制有了更全面的了解,促使研究人员开发了一个包含许多小分子的化合物库,这些小分子能特异性干扰破骨细胞前体细胞的生成。抑制破骨细胞分化的天然化合物在治疗与骨吸收相关的疾病(如骨质疏松症、类风湿性关节炎、骨转移和牙周病)方面可能具有治疗价值。本综述聚焦于目前对源自植物的多酚类物质的认识,这些多酚类物质可能有效抑制破骨细胞分化和骨吸收。